热门资讯> 正文

Soleno Therapeutics plunges after short report from Scorpion Capital

2025-08-15 21:16

Soleno Therapeutics (SLNO) dropped 16% in premarket trading after a new short report from Scorpion Capital.

Scorpion Capital disclosed that it's short Soleno Therapeutics (NASDAQ:SLNO).

Soleno (NASDAQ:SLNO) didn't immediately return Seeking Alpha's email request for comment.

Soleno has short interest of 11%.

More on Soleno Therapeutics

Soleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call Transcript
Soleno Therapeutics: Fairly Valued Despite M&A Expectations
Soleno Therapeutics: Overbought On VYKAT Approval Enthusiasm
Soleno signals $500M cash war chest and robust Vykat XR launch trajectory while advancing EU expansion
Soleno Therapeutics prices $200M public offering

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。